New Jersey Cannabis Commission to Hold Virtual Meetings on How Social Equity Excise Fee Dollars Should Be Spent

The New Jersey Cannabis Regulatory Commission (CRC) announced today it will host a series of virtual meetings to gather community input on the allocation of funds raised from the Social Equity Excise Fee (SEEF) on recreational cannabis sales.

“Input collected from public comments at the meetings and from written submissions will inform the Commission’s recommendations to the Governor and Legislature”, states a press release from the CRC.


The virtual meetings are scheduled as follows:

Northern region

·         Thursday, January 15, 2026, 1:30 to 2:30 p.m. (via Zoom)

Central region 

·         Wednesday, January 21, 2026, 1:30 to 2:30 p.m. (via Zoom)

Southern region

·         Thursday, January 29, 2026, 2 to 3 p.m. (via Zoom)

The CREAMM (Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization) Act, which legalized adult-use cannabis in 2021, requires that all tax revenue, fees, and fines collected by the NJ-CRC must be placed in the CREAMM Fund, and that the New Jersey Legislature appropriate investments in designated Impact Zones. The law specifies that SEEF funds from adult use cannabis sales are to be used for social equity investments. This could include assistance for those adversely affected by past marijuana convictions, more affordable housing, educational support, mental health services, or an increase in funding for workforce development programs.

The June 2025May 2024February 2023, and June 2022 recommendations to the Legislature can be found at nj.gov/cannabis/resources/reports-stats-info. The Social Equity Excise Fee is allocated by the New Jersey Legislature through the state budget. While the NJ-CRC sets the annual fee rate and conducts public input sessions to guide its recommendations, the Legislature determines final appropriations for social equity initiatives.

Though the meetings are open to everyone, the NJ-CRC seeks ideas specific to North Jersey on on Thursday, January 15, 2025, Central Jersey on January 21, 2026, and South Jersey on January 29, 2026. The public can register to speak or submit a written comment by going to nj.gov/cannabis/meetings and looking for the Upcoming Hearings link under the “Public Hearings” tab.

The New Jersey Cannabis Regulatory Commission establishes and enforces the rules and regulations governing the licensing, cultivation, testing, selling, and purchasing of cannabis in the state.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

More articles from The Marijuana Herald can be found below.

Study: Psilocybin Treatment May Benefit Those With PTSD

Study: Psilocybin Treatment May Benefit Those With PTSD

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical

Seven of Eight Remaining NFL Playoff Teams Come From States Where Recreational Marijuana Is Legal

Seven of Eight Remaining NFL Playoff Teams Come From States Where Recreational Marijuana Is Legal

Washington Bill Would Replace 37% Marijuana Excise Tax With Weight- and Potency-Based Rates

Washington Bill Would Replace 37% Marijuana Excise Tax With Weight- and Potency-Based Rates

Legal Cannabis Sales in U.S. Pass $2.3 Billion in December, $27 Billion in 2025

Legal Cannabis Sales in U.S. Pass $2.3 Billion in December, $27 Billion in 2025

Gelteq Reports Preclinical Results Showing Oral Gel Boosts CBD Absorption

Gelteq Reports Preclinical Results Showing Oral Gel Boosts CBD Absorption

Glass House and University of California Berkeley Secure $1.8 Million State Grant to Study Marijuana Crop Yields

Glass House and University of California Berkeley Secure $1.8 Million State Grant to Study Marijuana Crop Yields

Smart & Safe Florida Raises More Than $52 Million to Support 2026 Marijuana Legalization Initiative

Smart & Safe Florida Raises More Than $52 Million to Support 2026 Marijuana Legalization Initiative

Study: CBD Shown to Reduce Seizures Across Wide Range of Treatment-Resistant Epilepsies

Study: CBD Shown to Reduce Seizures Across Wide Range of Treatment-Resistant Epilepsies

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders